David Barounis MD

Critical care , medical director medical intensive care unit advocate Christ medical center, chief medical officer advocate intensivist partners

[David Barounis MD @DavidBarounis]

Gotta love this.

[David Gardner @byDavidGardner]

Norm MacDonald on battles with cancer: “I’m pretty sure, I’m not a doctor, but I’m pretty sure if you die, the cancer dies at the same time. That’s not a loss. That’s a draw.”

[David Barounis MD @DavidBarounis]

An important study was recently published looking at face mask coverings and the spread of COVID-19.
https://t.co/NWKDG0ScO5

[David Barounis MD @DavidBarounis]

Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia | NEJM https://t.co/uYW1OqKrBi

[David Barounis MD @DavidBarounis]

Recruit for #ICECAP at AAH sites begins this week. Interesting to see how the trial will compare to TTM2. Today’s presentation maybe practice changing for many. #TTM2trial

[David Barounis MD @DavidBarounis]

Will await the final print but RECOVERY trial demonstrates improved outcomes in those receiving tocilizumab. This is consistent with prior trials as well as trials using both toci and dexamethasone. https://t.co/eXg3wyXlRR

[@Sports is Watching the World Cup on FOX @Sports]

@Davidbarounis 👀

[rat king 🐀 @MikeIsaac]

There is an enormous demonstration going on at @Stanford Hospital right now carried out by staff, who are protesting the decision by higher ups to give vaccines to some administrators and physicians who are at home and not in contact with patients INSTEAD of frontline workers.

[David Barounis MD @DavidBarounis]

For posterity #IGotMine

[David Barounis MD @DavidBarounis]

@Elise_Lovell And stancati was the ICU doctor!

[David Barounis MD @DavidBarounis]

His work was mission critical, may his family and friends take some comfort in that.

[Segun Olusanya (He/Him) [email protected] @iceman_ex]

RIP.

This might be the first U.K. anaesthetist COVID death. @doctimcook @dannyjnwong

[Advocate Christ EM Residency @ACMCEM]

Winter Panel Series opens this week with a discussion on EM Critical Care Wed @7pm

featuring
@DavidBarounis, ACMC grad and medical director of ICU
@jstancc, ACMC grad and intensivist
@ma5880 PGY3, Northwestern critical care fellowship bound

RSVP to [email protected]

[David Barounis MD @DavidBarounis]

Thank you to all the residents that helped out during the initial wave of patients in mid-March. Thank you to Dr. Mukai for giving this lecture at ICEP!
@ACMCEM @ACMCIMRes @advocatehealth

[David Barounis MD @DavidBarounis]

@ACMCEM Love those guys!

[David Barounis MD @DavidBarounis]

@PulmCrit It’s really gotta be both.

[David Barounis MD @DavidBarounis]

Thank you @ACMCEM for allowing me to tell the evolving story about our experience with #covid19 So many people have been involved in keeping our patients safe while supporting each other through difficult times @advocatehealth @DoddMD @RajuMehtaMD @ngoodmanson

[Advocate Christ EM Residency @ACMCEM]

insightful (and at times incredible) presentation today from
@DavidBarounis reflecting on our first COVID surge at ACMC and lessons for the future (1/4)

#COVID #COVID19 #EmergencyMedicine #MedEd #EMed #TheACMCDifference

[David Barounis MD @DavidBarounis]

@LaurenStambolic @PharmD_ED @DharatiDesai @SNunezCruz @EMRxJaxson @ACMCEM @ChillaPharmD Amazing work! you guys/gals are the best

[David Barounis MD @DavidBarounis]

Wow

[Daniel Uhlfelder @DWUhlfelderLaw]

States w/ highest % positive COVID-19 tests (7-day avg)
1) Arizona: 25.7%.
2) Florida: 17.8%.
3) Nevada: 15.6%.
4) South Carolina: 15.1%.
5) Alabama: 14.5%.
6) Texas: 14.5%.
7) Mississippi: 13.7%.
8) Georgia: 13.4%.

[David Barounis MD @DavidBarounis]

Early use of tocilizumab appears to show a reduction in a composite endpoint of mortality + need for mechanical ventilation. We’re working on RCT data now ⁦@DoddMD⁩ ⁦⁦@AdvocateAurora⁩ ⁦@RajuMehtaMD⁩ https://t.co/aP6OKxWecV

[David Barounis MD @DavidBarounis]

Now let’s see the formal published results ASAP https://t.co/JvBM1PZhcQ

[David Barounis MD @DavidBarounis]

1/2 Part of our strategy from the beginning has been looking at the implementation of steroids in patients with #COVID19. We followed the DEXA-ARDS trial, and after intense internal debate, we adopted the approach based on crude inflammatory markers and

[David Barounis MD @DavidBarounis]

2/2 development of hypoxemia. There is more to this story, but it is plausible this accounts for a portion of the results we have seen. Thank you to our AIP team!
@advocatehealth @RajuMehtaMD @DoddMD @ngoodmanson @ECMOeydelman @AdvocateAurora